| Risk‐reducing salpingectomy: Let us be opportunistic KC Long Roche, NR Abu‐Rustum, M Nourmoussavi, O Zivanovic Cancer 123 (10), 1714-1720, 2017 | 48 | 2017 |
| Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma ML Fernandez, A Dawson, H Kim, N Lam, H Russell, M Bruce, M Bittner, ... Gynecologic Oncology 157 (1), 12-20, 2020 | 37 | 2020 |
| Carboplatin response in preclinical models for ovarian cancer: comparison of 2D monolayers, spheroids, ex vivo tumors and in vivo models MN Brodeur, K Simeone, K Leclerc-Deslauniers, H Fleury, E Carmona, ... Scientific reports 11 (1), 18183, 2021 | 36 | 2021 |
| Ovarian ablation for premenopausal breast cancer: A review of treatment considerations and the impact of premature menopause M Nourmoussavi, G Pansegrau, J Popesku, GL Hammond, JS Kwon, ... Cancer treatment reviews 55, 26-35, 2017 | 35 | 2017 |
| Carboplatin sensitivity in epithelial ovarian cancer cell lines: The impact of model systems B Patra, MA Lateef, MN Brodeur, H Fleury, E Carmona, B Peant, ... PLoS One 15 (12), e0244549, 2020 | 23 | 2020 |
| Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study J Van Schalkwyk, M Nourmoussavi, A Massey, R Gustafson, E Brodkin, ... Canadian Journal of Gastroenterology and Hepatology 28 (10), 525-528, 2014 | 19 | 2014 |
| Low-grade serous carcinoma (LGSC): a Canadian multicenter review of practice patterns and patient outcomes SA Scott, ML Fernandez, H Kim, L Elit, M Nourmoussavi, S Glaze, ... Gynecologic Oncology 157 (1), 36-45, 2020 | 18 | 2020 |
| Bladder base tenderness in the etiology of deep dyspareunia M Nourmoussavi, S Bodmer‐Roy, J Mui, N Mawji, C Williams, C Allaire, ... The Journal of Sexual Medicine 11 (12), 3078-3084, 2014 | 16 | 2014 |
| Long-term consequences of ovarian ablation for premenopausal breast cancer JS Kwon, G Pansegrau, M Nourmoussavi, G Hammond, MS Carey Breast Cancer Research and Treatment 157, 565-573, 2016 | 14 | 2016 |
| Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer MN Brodeur, R Dejean, MC Beauchemin, V Samouelian, B Cormier, ... Gynecologic oncology 162 (2), 277-283, 2021 | 12 | 2021 |
| Costs and benefits of extended endocrine strategies for premenopausal breast cancer JS Kwon, G Pansegrau, M Nourmoussavi, GL Hammond, MS Carey Journal of the National Comprehensive Cancer Network 15 (8), 1015-1021, 2017 | 12 | 2017 |
| Neoadjuvant radiotherapy and brachytherapy in endometrial cancer with gross cervical involvement: a CHIRENDO research group study MN Brodeur, V Samouëlian, Y Dabi, B Cormier, MC Beauchemin, ... International Journal of Gynecologic Cancer 31 (1), 2021 | 5 | 2021 |
| Machine learning for prediction of concurrent endometrial carcinoma in patients diagnosed with endometrial intraepithelial neoplasia G Levin, E Matanes, Y Brezinov, A Ferenczy, M Pelmus, MN Brodeur, ... European Journal of Surgical Oncology 50 (3), 108006, 2024 | 3 | 2024 |
| Interferon response and epigenetic modulation by SMARCA4 mutations drive ovarian tumor immunogenicity MN Brodeur, H Dopeso, Y Zhu, ALF Longhini, A Gazzo, S Sun, R Koche, ... bioRxiv, 2023.08. 08.552544, 2023 | 2 | 2023 |
| Association between BMI and oncologic outcomes in epithelial ovarian cancer: a predictors-matched case-control study G Levin, Y Brezinov, Y Tzur, T Bar-Noy, MN Brodeur, S Salvador, S Lau, ... Archives of Gynecology and Obstetrics, 1-7, 2024 | 1 | 2024 |
| Stability of hepatitis B viral load during pregnancy and implications for antepartum prophylaxis: A prospective cohort study CV Ommen, A Albert, M Nourmoussavi, R Gustafson, E Brodkin, M Petric, ... Canadian Liver Journal 2 (4), 190-198, 2019 | 1 | 2019 |
| GD2 and GD3 gangliosides as prognostic biomarkers in high grade serous ovarian cancer G Levin, E Matanes, A Yasmeen, R Meyer, MN Brodeur, S Salvador, ... Journal of Gynecology Obstetrics and Human Reproduction 54 (1), 102860, 2025 | | 2025 |
| Time interval from biopsy of endometrial intraepithelial neoplasia to surgery and risk for concurrent endometrial carcinoma G Levin, E Matanes, M Brodeur, S Salvador, S Lau, W Gotlieb Gynecologic Oncology 190, S359, 2024 | | 2024 |
| Intraperitoneal therapy with engineered Newcastle disease virus encoding interleukin-12 in combination with PD-1 blockade for ovarian cancer R Kahn, MA Ozsoy, H Green, K Gill, A Praiss, G Pesci, B Burman, ... Gynecologic Oncology 190, S200-S201, 2024 | | 2024 |
| EV335/# 1116 Ovarian cancer relapse pattern following robotic versus open cytoreduction Y Tzur, Y Brezinov, S Salvador, S Lau, G Levin, T Bar-Noy, M Brodeur, ... International Journal of Gynecologic Cancer 34 (Suppl 3), 2024 | | 2024 |
